<b>ADAM17 regulates TNF-α expression upon lipopolysaccharide stimulation in oral </b><b>keratinocytes </b>
-
- HIRAYAMA Aya
- Division of Community Oral Health Development, Kyushu Dental University
-
- AWANO Shuji
- Department of Clinical Education Development and Research, Kyushu Dental University
-
- SETA Yuji
- Department of Anatomy, Kyushu Dental University
-
- ANSAI Toshihiro
- Division of Community Oral Health Development, Kyushu Dental University
Search this article
Abstract
<p>A disintegrin and metalloprotease 17 (ADAM17) is a tumor necrosis factor (TNF)-converting enzyme and was first identified as the enzyme that cleaves the prodomain of TNF-α, a proinflammatory cytokine that plays a central role in immune regulation and a variety of inflammatory responses in destructive periodontal disease. The aim of the present study was to verify the presence of ADAM17 in the gingival epithelium and elucidate its involvement in the release of TNF-αin oral keratinocytes. Immunohistochemical analyses of ADAM17 were performed in gingival tissues obtained from patients and in human oral keratinocytes (HOKs). Additionally, levels of TNF-α and ADAM17 in HOKs exposed to lipopolysaccharide (LPS) were assessed using enzyme-linked immunosorbent assays. Moreover, the effects of ADAM17 inhibitor, matrix metalloproteinase (MMP) inhibitor, and ADAM17 siRNA on TNF-α concentration were assessed. Strong immunoreactivity for ADAM17 was observed in the epithelium of the inflamed gingival tissues and in HOKs. Furthermore, treatment with either ADAM17 inhibitor or ADAM17 siRNA inhibited the generation of TNF-α induced by LPS in HOKs. The present study demonstrates that ADAM17 is strongly expressed in the epithelium of gingival tissues and suggests that ADAM17 may be a key enzyme that regulates the generation of TNF-α in oral keratinocytes.</p>
Journal
-
- Biomedical Research
-
Biomedical Research 38 (3), 157-165, 2017
Biomedical Research Press